• New Life Tech Products Use Compendia Gene Database

    Bio-IT World Product Briefs | Life Technologies Corporation announced two new offerings this morning that give users access to the large genomics database compiled by Compendia Biosciences, which the company acquired in October 2012.

    Apr 4, 2013
  • Life Sciences Survey Reveals IT Outlooks and Plans for 2013

    Bio-IT World | The first in an annual series, Bio-IT World's 2013 Life Sciences IT Survey captures a host of trends in bio-IT for the coming year. The forecast: increasing budgets, almost certain data increases, and more clouds.

    Apr 4, 2013
  • Pfizer and BIND Therapeutics Sign Nanotech Drug Deal

    Boston Globe | BIND Therapeutics (recently rechristened from BIND Biosciences) has signed a $160 million per drug collaboration with Pfizer to develop targeted medicines with nanotechnology.

    Apr 3, 2013
  • From Junk DNA to Junk Economics: Beware the Inexorable Sovietization of Big Science

    Bio-IT World The Skeptical Outsider |The controversy surrounding the $400-million Encode project’s dubious public relations claims surrounding the function of ‘junk DNA’ and the Battelle Institute’s defense of the $3-billion Human Genome Project (HGP) as economically beneficial (as cited in the recent State of the Union address) make this a good time to examine President Obama’s attempts to bring more of American science under centralized direction and control.

    Apr 3, 2013
  • The Most Dangerous Words in Genetics

    Wired | Geneticist Steve Jones captures the most dangerous words in genetics: "the gene for."

    Apr 2, 2013
  • Obama Launches Brain Map

    New York Times | Following hints of the announcement after his State of the Union address in January, President Obama will today formally launch the Brain Research Through Advancing Innovative Neurotechnologies, or Brain for short.

    Apr 2, 2013
  • IBM Provides Almost One Fifth of Cloud Infrastructure

    eWeek | The cloud infrastructure market grew for most major players in the last quarter of 2012, but IBM's share of the market hit a two-year high.

    Apr 2, 2013
  • Cycle Computing Launches ZeroCompute

    Bio-IT World News Brief | CycleComputing is set to revolutionize supercomputing with their new offering today: ZeroCompute. The new intelligent orchestration software is designed to accelerate access to HPC and BigData systems.

    Apr 1, 2013
  • Amgen Mulls Future of deCODE’s Clinical Sequence Miner Platform

    Bio-IT World | BOSTON—An interview with Kari Stefansson, the co-founder, CEO, heart and soul of deCODE Genetics, is an experience quite unlike any other biotech executive briefing. Stefansson agreed to an interview during a pit stop in Boston late year, en route to Los Angeles for a trip that was part business, part pleasure. He would be paying a visit to Amgen. A few weeks later, Amgen announced that it was acquiring the Icelandic firm for a cool $415 million.

    Mar 29, 2013
  • Genetic Marketing? Apparently It's On the Way

    Wired | Miinome--a new start up boasting George Church as an advisor--is building a platform that will enable retailers to target advertisements to consumers based on their genetic makeup.

    Mar 29, 2013
  • Amazon-Stored Data Exposed Thanks to Faulty User Settings

    eWeek | A security audit found that one in six data storage "buckets" on Amazon's S3 storage service is incorrectly set to public. Conducted by vulnerability firm Rapid7, the audit scanned over 12,000 buckets

    Mar 29, 2013
  • Next in Cloud: DaaS, MaaS, DRaaS

    ReadWrite | Cloud spending is only set to increase in 2013, and according to Gartner, offerings will become more specialized. The company predicts Desktop-as-a-Service (DaaS), Metal-as-a-Service (MaaS) and DisasterRecovery-as-a-Service (DRaaS) to lead the new product market in 2013.

    Mar 29, 2013
  • Davies on Bioinformatics, Genomics

    MendelsPod | Bio-IT World’s own Kevin Davies, editor-in-chief, shares his thoughts on bioinformatics. This last year has seen a flowering of new companies offering genome interpretation and reporting, but what will success for these early entrants look like?

    Mar 28, 2013
  • Canadian Scientist Declines Gairdner Award

    The Scientist | Michael Houghton, a Canadian microbiologist and immunologist, declined the prestigious Gairdner International Award because he said two colleagues were also deserving of the prize.

    Mar 28, 2013
  • IT's Role Combating the Alien Invader

    Bio-IT World Video | At the Bio-IT World Expo last year, an all star panel took on the challenges of combating cancer and “characterizing the alien invader”. Our opportunities in cancer therapies are driven by the availability of data, the panel contented, and our challenges lie in integrating the data. On the eve of the 2013 event, we evaluate our progress.

    Mar 28, 2013
  • Small Data Centers Move to the Cloud

    ComputerWorld | Day is waning for small in-house data centers, says ComputerWorld. Large firms have been consolidating data centers for a while now, but the trend is now trickling down to smaller groups.

    Mar 28, 2013
  • The Newest 'Ome' for Sequencing Studies: the Squishome

    GigaScience | Ready for the next frontier of NGS research? Bug guts. Today in GigaScience, researchers publish a "squishomics" approach to studying biodiversity.

    Mar 27, 2013
  • Privacy Debates Over HeLa Cell Sequence

    ScienceInsider | A debate has been raging over the ethics of sequencing the HeLa cell line without the consent of Henrietta Lacks' family, and many in the community have weighed in.

    Mar 26, 2013
  • Nimbus Releases New Flash Storage Software

    SemiAccurate | Nimbus Data released a software suite--Halo 2013--for their flash storage offerings. The software is a free update for existing customers and brings an analysis system, API, and mobile monitoring suite.

    Mar 26, 2013
  • Systems Biology Initiative Plans Computer-Simulated Skin Model

    News Brief | Bio-Modeling Systems (BMSystems) of France and Persistent Systems of India are launching a joint systems biology research and development initiative that will marry non-mathematical heuristic modeling with mathematical modeling designed to increase the success rates of drug discovery and formulation development.

    Mar 25, 2013